These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2160146)

  • 1. Biochemical and physical properties of a solvent-detergent-treated fibrin glue.
    Burnouf-Radosevich M; Burnouf T; Huart JJ
    Vox Sang; 1990; 58(2):77-84. PubMed ID: 2160146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma.
    Horowitz B; Bonomo R; Prince AM; Chin SN; Brotman B; Shulman RW
    Blood; 1992 Feb; 79(3):826-31. PubMed ID: 1310064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale production and properties of a solvent-detergent-treated factor IX concentrate from human plasma.
    Michalski C; Bal F; Burnouf T; Goudemand M
    Vox Sang; 1988; 55(4):202-10. PubMed ID: 3265237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of human thrombin for use in a fibrin glue.
    Rock G; Neurath D; Semple E; Harvey M; Freedman M
    Transfus Med; 2007 Jun; 17(3):187-91. PubMed ID: 17561860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of biological glues: cryoprecipitate glue, two-component fibrin sealant, and "French" glue.
    Basu S; Marini CP; Bauman FG; Shirazian D; Damiani P; Robertazzi R; Jacobowitz IJ; Acinapura A; Cunningham JN
    Ann Thorac Surg; 1995 Nov; 60(5):1255-62. PubMed ID: 8526609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of lipid-enveloped viruses in labile blood derivatives by unsaturated fatty acids.
    Horowitz B; Piët MP; Prince AM; Edwards CA; Lippin A; Walakovits LA
    Vox Sang; 1988; 54(1):14-20. PubMed ID: 2831669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autologous fibrin glue from preoperative blood or plasma donors].
    Wagner R; Matthes G
    Beitr Infusionsther Transfusionsmed; 1994; 32():96-8. PubMed ID: 9480167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New method to prepare autologous fibrin glue on demand.
    Alston SM; Solen KA; Broderick AH; Sukavaneshvar S; Mohammad SF
    Transl Res; 2007 Apr; 149(4):187-95. PubMed ID: 17383592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin glue from stored human plasma. An inexpensive and efficient method for local blood bank preparation.
    Spotnitz WD; Mintz PD; Avery N; Bithell TC; Kaul S; Nolan SP
    Am Surg; 1987 Aug; 53(8):460-2. PubMed ID: 2440358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of platelets in the production of cryoprecipitates for use in a fibrin glue.
    Rock G; Neurath D; Lu M; Alharbi A; Freedman M
    Vox Sang; 2006 Oct; 91(3):252-5. PubMed ID: 16958838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the products of cryoprecipitation: RiCoF is deficient in cryosupernatant plasma.
    Freedman M; Rock G
    Transfus Apher Sci; 2010 Oct; 43(2):179-82. PubMed ID: 20719565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the mechanical, kinetic, and biochemical properties of fibrin clots formed with two different fibrin sealants.
    Hickerson WL; Nur I; Meidler R
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):19-23. PubMed ID: 21150581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin digestion by thrombin. Comparison with plasmin-digested fibrinogen.
    Kang EP; Triantaphyllopoulos DC
    Biochim Biophys Acta; 1977 Feb; 490(2):430-42. PubMed ID: 138448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of factor XIII as a component of fibrin sealants.
    Dickneite G; Metzner HJ; Kroez M; Hein B; Nicolay U
    J Surg Res; 2002 Oct; 107(2):186-95. PubMed ID: 12429174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autologous fibrin glue--preparation and clinical use].
    Kjaergård HK; Weis-Fogh US; Sørensen H; Thiis JJ; Rygg I
    Ugeskr Laeger; 1992 May; 154(22):1554-6. PubMed ID: 1631981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical, mechanical, and morphological properties of a completely autologous platelet-rich wound sealant.
    Wu X; Ren J; Luan J; Yao G; Li J
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):290-5. PubMed ID: 22395185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral safety of solvent-detergent treated blood products.
    Horowitz B; Prince AM; Horowitz MS; Watklevicz C
    Dev Biol Stand; 1993; 81():147-61. PubMed ID: 8174797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative procurement of autologous fibrin glue.
    Quigley RL; Perkins JA; Gottner RJ; Curran RD; Kuehn BE; Hoff WJ; Wallock ME; Arentzen CE; Alexander JC
    Ann Thorac Surg; 1993 Aug; 56(2):387-9. PubMed ID: 8347035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fibrin glues on the mechanical properties of healing wounds.
    Byrne DJ; Hardy J; Wood RA; McIntosh R; Cuschieri A
    Br J Surg; 1991 Jul; 78(7):841-3. PubMed ID: 1714789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Important factors influencing the strength of autologous fibrin glue; the fibrin concentration and reaction time--comparison of strength with commercial fibrin glue.
    Kjaergard HK; Weis-Fogh US
    Eur Surg Res; 1994; 26(5):273-6. PubMed ID: 7835384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.